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Edited by Takashi GojoboriAbstract It has been controversial whether the ClC-2 chloride
channel is involved in hydrochloric acid secretion of gastric
parietal cells. Here, we investigated whether ClC-2 is the apical
Cl channel associated with gastric acid secretion. Two anti-
ClC-2 antibodies used in this study reacted with cloned ClC-2
protein expressed in HEK293 cells. In isolated rabbit gastric
glands, signiﬁcant expression of ClC-2 mRNA was observed, but
the presence of ClC-2 protein was not clear. Furthermore, no
expression of ClC-2 protein was observed in isolated rat and
human gastric mucosa. Immunohistochemistry on the rat gastric
mucosa showed no signiﬁcant expression of ClC-2 protein in the
parietal cells which showed abundant expression of Hþ,Kþ-
ATPase. These results indicate that ClC-2 may not be a Cl-
transporting protein for gastric acid secretion in parietal cells.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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ClC-2 is a broadly expressed Cl channel activated by hy-
perpolarization, cell swelling and acidic pH (for review see
[1,2]). This channel has been suggested to contribute to epi-
thelial Cl secretion in human and rat airways [3] and rat fetal
lung [4–6] because the channel protein is expressed in the apical
membrane of these epithelia. Although ClC-2 knockout mice
showed no gross anatomical or histological changes during the
lung development, it does not rule out the possibility that ClC-
2 participates in pulmonary transepithelial Cl transport [7].
ClC-2 has also been suggested to be involved in maintaining
the inhibitory GABA response (for review see [1]). The ClC-2
knockout mice revealed a degeneration of photoreceptors
and male germ cells that led to the total loss of both cell types
in adults, suggesting an important role of ClC-2 for cells
depending on close cell–cell interactions [7].
In the stomach, protons are actively secreted by Hþ,Kþ-
ATPase present in the apical membrane of gastric parietal
cells, but it has not been established what molecule contributes* Corresponding author. Fax: +81-76-434-5051.
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Concerning the involvement of ClC-2 in gastric acid secretion,
the results so far reported are divided and controversial.
One group has reported that ClC-2 is the apical Cl channel
that may be involved in gastric acid secretion of parietal cells
based on the following results: (1) ClC-2 was cloned from
rabbit gastric mucosa [8] and its electrophysiological proper-
ties including anion selectivity (I >Cl) are similar to those of
the native channel in Hþ,Kþ-ATPase-containing gastric vesi-
cles [9]. (2) ClC-2 of rabbits [8] and humans [10] is activated by
cAMP-dependent phosphorylation, and this mechanism is
consistent with an essential role of intracellular cAMP in the
HCl secretory mechanism. (3) Anti-ClC-2 antibody showed
signals in rabbit gastric parietal cells [11].
In contrast, another group suggested that ClC-2 is not as-
sociated with gastric acid secretion [1] based on the following
results: (1) Histamine-stimulated gastric acidiﬁcation in ClC-2-
deﬁcient mice was not signiﬁcantly diﬀerent from that in wild-
type mice [7]. (2) Anion selectivity of ClC-2 cloned from rats
and rabbits is Cl > I [12–14]. (3) ClC-2 of rats [1] and rabbits
[14] cannot be activated by cAMP-dependent phosphorylation.
We investigated whether ClC-2 is expressed in the gastric
mucosa of rabbits, rats and humans in the present study, where
positive and negative control experiments were performed. We
found no signiﬁcant expression of ClC-2 protein in the gastric
mucosa.2. Materials and methods
2.1. Preparation of gastric samples
Rabbit gastric glands and parietal cells were prepared from male
Japanese white rabbits weighing 2–2.5 kg as previously described [15],
and rat gastric mucosa was obtained from female Sprague–Dawley rats
weighing 200–300 g [16]. Animals were humanely killed in accordance
with the guidelines presented by the Animal Care and Use Committee
of Toyama Medical and Pharmaceutical University [15,16]. Hog gas-
tric vesicles rich in Hþ,Kþ-ATPase were prepared as described else-
where [17]. Human gastric specimens were obtained from surgical
resection of two Japanese patients with gastric cancer (76 years, male
and 60 years, female) in accordance with the recommendations of the
Declaration of Helsinki. Informed consents were obtained from the
patients at Toyama Medical and Pharmaceutical University Hospital.
The normal gastric mucosae used for the experiments were 10–20 cm
apart from the carcinoma. Rat and human preparations of mucosa
were free from muscle layer.blished by Elsevier B.V. All rights reserved.
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Poly (Aþ) RNA was prepared from isolated rabbit gastric parietal
cells as previously described [15]. A set of primers based on the rabbit
ClC-2 sequence (nucleotide positions 490–512: 50-GGGTC-
CGGCATCCCCGAGATGAA-30 and nucleotide positions 781–803:
50-ACCTCAATGCTGAATAGGACGCC-30) was used for PCR. The
ampliﬁed products were sequenced and used for the preparation of the
32P-labeled cDNA probes. Northern blot analysis was performed as
described elsewhere [18].
2.3. Cell culture and transfection
HEK293 cells were maintained in Dulbecco’s Modiﬁed Eagle’s
Medium (Invitrogen, Carlsbad, CA) supplemented with 10% fetal
bovine serum. The cells were transfected with rabbit ClC-2 cDNA
subcloned into pcDNA3.1 (+) [19] by using Lipofectamine 2000
(Invitrogen). The cells were cultured for two days and used for the
following fractionation.
2.4. Fractionation of gastric samples and cultured cells
Isolated rat and human gastric mucosa, isolated rabbit gastric glands
or HEK cultured cells were homogenized in the buﬀer (250 mM su-
crose, 1 mM EDTA and 20 mM Tris–HCl, pH 7.4) supplemented with
10 lg/ml phenylmethylsulfonyl ﬂuoride, 1 lg/ml leupeptin, 1 lg/ml
pepstatin A and 15 lg/ml aprotinin. The P1, P2, P3 and S fractions
were prepared by the following three steps at 4 C [20]. (1) The ho-
mogenate was centrifuged at 1400 g for 10 min. The supernatant was
collected, and the pellet was homogenized and centrifuged again. This
procedure was repeated three times. The resulting pellet was suspended
with the buﬀer (P1 fraction). (2) The supernatant from the step 1 was
centrifuged at 5900 g for 15 min. Then, the supernatant was col-
lected, and the pellet was homogenized and centrifuged again. This
procedure was repeated twice. The resulting pellet was suspended with
the buﬀer (P2 fraction). (3) The supernatant from the step 2 was
centrifuged at 105 000 g for 60 min. Then, the pellet (P3 fraction) and
the supernatant (S fraction) were separated. These four fractions were
rich in cell debris and nuclei (P1), mitochondria (P2), microsome and
plasma membrane (P3) and cytosol (S), respectively [20,21]. In the case
of human preparation and HEK cultured cells, step 2 was skipped.
2.5. Sodium dodecyl sulfate (SDS)–polyacrylamide gel electrophoresis
and Western blotting
The fractions P2, P3, P2+P3 and S (each 30 lg of protein) or hog
gastric vesicles (1 lg of protein) were incubated in a sample buﬀer
containing 2% SDS, 5% b-mercaptoethanol, 10% glycerol and 65 mM
Tris–HCl (pH 6.8) at room temperature for 5 min and applied to the
SDS–polyacrylamide gel. Western blotting was carried out as de-
scribed previously [22]. We used two polyclonal anti-ClC-2 antibodies,
CLC21-A (1:500 dilution; Alpha Diagnostic, TX, USA) and ACL-002
(1:400 dilution; Alomone Labs, Jerusalem, Israel), and a monoclonal
anti-Hþ,Kþ-ATPase a subunit antibody, 1H9 (1:200 dilution; Medical
& Biological Laboratories, Nagoya, Japan). For negative control, 10
lg of the anti-ClC-2 antibody was pre-incubated with 10 lg of the
corresponding blocking peptide. The CLC21-A blocking peptide (Al-
pha Diagnostic) that corresponded to 22 amino acid residues near the
C-terminus of rat ClC-2 is 100% conserved in rabbit and 90% in hu-
man, and the ACL-002 blocking peptide (Alomone Labs) that corre-
sponded to amino acid residues 888–906 of rat ClC-2 is 95% conserved
in rabbit and 90% in human. Horseradish peroxidase-conjugated
anti-rabbit IgG (1:5000 dilution) was used as a secondary antibody.Fig. 1. High expression of the protein of Hþ,Kþ-ATPase a subunit in
the P3 fraction from rabbit gastric glands, and from rat and human
gastric mucosa. Western blotting was performed in hog gastric vesicles
(a positive control), rabbit P2, P3 and S fractions (left panel), rat P2
and P3 fractions (left and right panels) and human P2+P3 fraction
(right panel). Monoclonal antibody 1H9 was used for the detection of
Hþ,Kþ-ATPase a subunit (100 kDa). In the human sample, age (years)
and sex (M or F) of the patient are shown in the upper parenthesis.2.6. Immunohistochemistry
Fresh-frozen rat gastric tissues embedded in the O.C.T. compound
were cut at 5 lm. The ClC-2-transfected HEK cells and the corre-
sponding mock cells were cultured on the collagen-coated cover glass.
The tissue sections and the cultured cells were ﬁxed in 4% parafor-
maldehyde for 30 min at room temperature, and the cells were sub-
sequently permeabilized with the phosphate buﬀered saline (pH 7.4)
containing 0.3% Triton X-100 and 0.1% bovine serum albumin. These
samples were treated with 20 mM phosphate buﬀer (pH 7.4) containing
450 mM NaCl, 16.7% goat serum and 0.3% Triton X-100 for 30 min.
Then, the samples were reacted with the anti-ClC-2 antibody (ACL-
002 or CLC21-A) or the anti-Hþ,Kþ-ATPase a subunit antibody
(1H9) for 15–20 h at 4 C. These primary antibodies were used at 1:100
dilution. As a secondary antibody, Alexa Fluor 546-conjugated anti-
rabbit IgG (1:100 dilution) or Alexa Fluor 488-conjugated anti-mouseIgG (1:100 dilution) was used. The stained samples were observed
under the ﬂuorescent microscope (BX50-34-FLA-2, Olympus, Tokyo,
Japan).3. Results and discussion
Gastric acid (HCl) secretion is one of the fundamental
physiological functions in all mammals. The amino acid se-
quence of the Hþ,Kþ-ATPase, which actively secretes Hþ in
the apical membrane of gastric parietal cells, is highly con-
served among diﬀerent species of animals [23,24], but the
Cl-transporting molecule for HCl secretion has not been
established yet. A potential candidate is the ClC-2 Cl channel
[8–11], but this is still controversial [1]. In the present study, we
examined if ClC-2 protein is expressed in parallel with the
Hþ,Kþ-ATPase in the gastric mucosa of rabbits, rats and
humans.
First, we checked the expression of the Hþ,Kþ-ATPase a
subunit protein in several gastric fractions from rabbits, rats
and humans. As expected, the Hþ,Kþ-ATPase is abundantly
expressed in the P3 fraction which is rich in microsomes and
plasma membrane (Fig. 1).
Fig. 2A shows that ClC-2 mRNA (3.3 kb) is signiﬁcantly
expressed in rabbit gastric parietal cells. This result is in
agreement with the previous report showing that ClC-2
mRNA is localized to the parietal cells by in situ hybridization
and by direct in situ RT-PCR [11]. In the Western blotting
using two anti-ClC-2 antibodies (CLC21-A and ACL-002),
several bands similar to ClC-2 protein (97 kDa), at least in
molecular size, were observed in P2, P3 and S fractions of
rabbit (Fig. 2B and C). Surprisingly, these bands did not dis-
appear in the presence of the blocking peptide, while the spe-
ciﬁc band for cloned ClC-2 (97 kDa) completely disappeared
(Fig. 2B and C). In the blot with ACL-002, the non-speciﬁc
band of 130 kDa in the S fraction unexpectedly disappeared in
the presence of the blocking peptide (Fig. 2C). These results
indicate that the bands (97 kDa) in P2, P3 and S fractions are
not due to ClC-2 protein.
Sherry et al. [11] reported the presence of ClC-2 protein
in rabbit gastric parietal cells as determined by Western blot-
ting and by immunohistochemistry using ACL-002 antibody.
Fig. 2. Expression of ClC-2 in the rabbit gastric samples. (A) Detection
of ClC-2 mRNA on poly (Aþ) RNAs (2.5 lg) of isolated rabbit gastric
parietal cells. A single band of 3.3 kb was detected. (B,C) No signiﬁ-
cant expression of ClC-2 protein in rabbit gastric glands. Western
blotting was performed with rabbit P2, P3 and S fractions using
CLC21-A (B) and ACL-002 (C) polyclonal antibodies. As a positive
control (indicated as cloned ClC-2), the P2+P3 fraction from the
HEK293 cells that were transfected with cloned rabbit ClC-2 was used.
The speciﬁc bands for the cloned ClC-2 (97 kDa) disappeared in the
presence of the corresponding blocking peptide (+BP; right panels).
Fig. 3. No expression of ClC-2 protein in rat gastric mucosa. Western
blotting was performed with rat P2 and P3 fractions using CLC21-A
(A) and ACL-002 (B) polyclonal antibodies. As a positive control, the
P2+P3 fraction from the HEK293 cells that were transfected with
cloned rabbit ClC-2 was used. The speciﬁc bands for the cloned ClC-2
(97 kDa) disappeared in the presence of the corresponding blocking
peptide (+BP; right panels).
Fig. 4. No expression of ClC-2 protein in human gastric mucosa.
Western blotting was performed with human P2+P3 fraction using
CLC21-A (A) and ACL-002 (B) polyclonal antibodies. Age (years) and
sex (M or F) of the patient are shown in the upper parenthesis. As a
positive control, the P2+P3 fraction from the HEK293 cells that were
transfected with cloned rabbit ClC-2 was used.
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there are several possible reasons to generate the diﬀerences.
(1) In the Western blotting, they observed a 93-kDa protein
band in rabbit gastric vesicles, but they performed no control
experiment using the blocking peptide [11]. Therefore, it is
likely that the 93-kDa band may be non-speciﬁc as observed in
the present experiment (97-kDa band; Fig. 2B and C). (2) In
the immunohistochemistry, they found that major staining was
present in the parietal cells, and the staining was weakened by
pre-incubating the antibody with the blocking peptide [11].
This weakening may be due to contribution of the 130-kDa
protein (Fig. 2C) to the staining. In fact, the 130-kDa band is
highly sensitive to the blocking peptide (Fig. 2C). It seems to
be inappropriate to use ACL-002 antibody for obtaining the
positive evidence for the presence of ClC-2 protein from the
immunohistochemical study on the rabbit gastric tissue be-
cause of its non-speciﬁc reactivity (Fig. 2C). Taken together, it
is suggested that ClC-2 mRNA is expressed, but the presence
of ClC-2 protein is not clear in rabbit gastric parietal cells.Next, we studied the presence of ClC-2 protein in rat and
human gastric mucosa. In the Western blotting using CLC21-
A and ACL-002 antibodies, no signal for ClC-2 protein was
detected in P2 and P3 fractions from rat gastric mucosa
(Fig. 3) and the P2+P3 fraction from human gastric mucosa
(Fig. 4).
In the immunohistochemistry, both CLC21-A and ACL-002
antibodies reacted with the cloned ClC-2 protein expressed in
HEK293 cells, while these antibodies showed no reactivity
with endogenous proteins in the mock cells (Fig. 5A). Fig. 5B
shows that CLC21-A and ACL-002 antibodies gave no signals
in the parietal cells of the rat gastric tissue section. Only the
Fig. 5. Immunohistochemical detection of ClC-2 protein. (A) Immu-
nostaining was performed with the HEK293 cells expressing the cloned
ClC-2 and the corresponding mock cells using CLC21-A (upper two
panels) and ACL-002 (lower two panels) primary antibodies and the
Alexa Fluor 546-conjugated secondary antibody. Positive signals were
observed only in the ClC-2-transfected cells. Bar¼ 50 lm. (B) Immu-
nostaining was performed with the rat gastric tissue using the CLC21-
A (top panel) and ACL-002 (middle panel) primary antibodies and the
Alexa Fluor 546-conjugated secondary antibody. These two panels
show signals of ClC-2 in the muscularis mucosae but not them in the
gastric parietal cells. As a positive control, the tissue was stained with
1H9 primary antibody against Hþ,Kþ-ATPase and the Alexa Fluor
488-conjugated secondary antibody (bottom panel). Speciﬁc signals of
Hþ,Kþ-ATPase are observed in the parietal cells. On these panels, the
surface epithelial layers are present on the left side and the submucosal
layers on the right side. Bar¼ 50 lm.
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(Fig. 5B). On the other hand, the anti-Hþ,Kþ-ATPase anti-
body (1H9) showed clear signals in the parietal cells of the
tissue section (Fig. 5B).
Our present results suggest that no signiﬁcant amount of
ClC-2 protein is expressed in rat and human gastric mucosa.
Therefore, ClC-2 may not be a Cl channel in the apical
membrane of the gastric parietal cells, although the channel
mRNA is expressed in the cells. At present, the Cl-trans-
porting molecule for gastric acid secretion is unknown and it
would be an interesting subject to be clariﬁed in a future study.
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